Cowen and Company, LLC 7th Annual Consumer Conference in New York City
HEILONGJIANG, China, Jan. 5 /PRNewswire-Asia/ -- Yanglin Soybean, Inc. (OTC Bulletin Board: YSYB) ("Yanglin" or the "Company"), a leading producer and processor of high-quality, non-genetically modified (non-GM) soybean products in China, today announced that it has been invited to make a corporate presentation at Cowen and Company, LLC's 7th Annual Consumer Conference in New York City.
The Company announced today that it has accepted an invitation to present at the Cowen and Company, LLC 7th Annual Consumer Conference. This conference will be held from Monday, January 12th through Tuesday, January 13th, 2009 at The Westin Times Square in New York. Details of Yanglin's presentation at the conference are as follows:
Date: Tuesday, January 13, 2009
Time: 2:00 - 2:25 P.M. Eastern Standard Time
Venue: Gershwin II, 4th Floor
Yanglin's management team will send three representatives to attend the conference, including Chief Financial Officer, Mr. Bode Xu, COO and Director, Mr. Zongtai Guo, and Director Mr. Yang Miao. The Company's management team will be available to meet with analysts and portfolio managers during this two-day event.
"We are pleased to have the opportunity to present at the Cowen conference," said Mr. Shulin Liu, Yanglin's Chief Executive Officer. "Yanglin is an exciting growth story and we look forward to meeting with institutional investors to share our vision and corporate strategy."
About Yanglin
Yanglin Soybean, Inc. is a leading non-genetically modified (non-GM) soybean processor in China. The Company manufactures soybean oil, salad oil and soybean meal with an annual processing capacity of 520,000 metric tons in 2008. During the first nine months of 2008, total revenues reached US$190.2 million. The Company's products are sold directly to its customers or through distributors. The majority of Yanglin Soybean's customers are located in Northern China.
Forward Looking Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this press release and oral statements made by the Company constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These statements include, without limitation, statements regarding our ability to prepare the company for growth, the Company's planned capacity expansion in 2008 and predictions and guidance relating to the Company's future financial performance. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs but they involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as unanticipated changes in product demand especially in the pharmaceutical industry, pricing and demand trends for the Company's products, changes to government regulations, risk associated with operation of the Company's new facilities, risk associated with large scale implementation of the company's business plan, the ability to attract new customers, ability to increase its product's applications, cost of raw materials, downturns in the Chinese economy, and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission. Investors are urged to consider these factors carefully in evaluating the forward-looking statements herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.
